Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

Thu, 22nd Feb 2024 09:55

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Indivior is a pharmaceutical company based in North Chesterfield, Virginia. Shares in the company were up 18% at 1,606.00 each in London on Thursday morning.

In the year to December 31, the company delivered USD1.09 billion in revenue, up 21% from USD901 million in 2022. Revenue in the fourth quarter was up 22% year-on-year to USD293 million from USD241 million.

The majority of revenue came from Sublocade, Indivior's medication for moderate to severe opioid addiction. In 2023, Sublocade revenue was USD630 million, 54% ahead of USD408 million the year before.

Indivior reported a nominal pretax profit of USD1 million in 2023, swinging from a loss of USD95 million in 2022.

Looking ahead, Chief Executive Officer Mark Crossley said that the company was eyeing "double-digit net revenue growth and meaningful operating margin expansion" in 2024.

Indivior forecasts net revenue of between USD1.24 billion and USD1.33 billion for 2024, with revenue guidance for Sublocade predicting USD820 million and USD880 million, a 35% increase at the mid-point.

Adjusted operating profit is predicted to rise some 32% to between USD330 million and USD380 million from USD269 million in 2023, which itself was a 27% rise from 2022.

Inidivior said it is "initiating shareholder consultations to potentially transition to a primary listing in the US" this year. It would maintain a secondary listing in the UK.

The London Stock Exchange, which has struggled to attract sizeable new listings, has also suffered a string of high-profile transfers of primary listings. Building materials firm CRH PLC moved its primary listing to New York in September. Plumbing and heating products supplier Ferguson PLC did the same in May 2022, months after miner BHP Group Ltd shifted its main listing to Sydney.

More recently, Paddy Power owner Flutter Entertainment announced it was looking to move its primary listing to New York. It would mean the firm is no longer eligible to be listed on the FTSE 100.

By Hugh Cameron, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its lis...

25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net ...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 eac...

12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.